What does mildly impaired renal function mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Cystatin C 1.08 mg/L

A cystatin C level of 1.08 mg/L indicates mildly impaired renal function, corresponding to an estimated GFR in the range of 45-60 mL/min/1.73 m² (CKD Stage G3a), which represents mild to moderate kidney dysfunction that warrants monitoring and risk factor modification. 1

What This Value Means

  • Cystatin C of 1.08 mg/L is elevated above the normal threshold of <1.0 mg/L, indicating reduced glomerular filtration rate even when serum creatinine may still appear normal 1, 2

  • This level suggests CKD Stage G3a (GFR 45-59 mL/min/1.73 m²), which is classified as "mildly to moderately decreased" kidney function 1

  • Importantly, cystatin C can detect renal impairment earlier than creatinine alone, particularly in patients with normal or near-normal creatinine levels who actually have reduced GFR 1, 3

Clinical Significance and Risk Implications

  • Elevated cystatin C (≥1.0 mg/L) is an independent predictor of adverse cardiovascular events, with patients showing significantly higher cardiac event rates (38.7% vs 10.3%) compared to those with normal levels 2

  • Even mild renal dysfunction at this level increases cardiovascular risk and requires more intensive risk factor management 1

  • This degree of kidney impairment places patients at moderately increased risk for CKD progression according to KDIGO risk stratification 1

Recommended Monitoring and Management

Monitoring frequency: Screen or monitor kidney function 1-2 times per year at this GFR level (Stage G3a) 1

Essential laboratory assessments:

  • Measure urinary albumin-creatinine ratio (UACR) to assess for albuminuria, which further stratifies risk 1
  • Check serum creatinine and calculate eGFR using MDRD or CKD-EPI equations for comparison 1
  • Monitor electrolytes (potassium, bicarbonate), calcium, phosphorus, and parathyroid hormone 4
  • Assess hemoglobin and iron studies for anemia of CKD 4

Blood pressure management:

  • Optimize blood pressure control to reduce CKD progression risk 1
  • If albuminuria is present (UACR ≥30 mg/g), initiate ACE inhibitor or ARB therapy 1

Medication adjustments:

  • Review and dose-adjust all renally cleared medications for GFR 45-60 mL/min/1.73 m² 4
  • Avoid nephrotoxic agents including NSAIDs, aminoglycosides, and minimize contrast exposure 4

Important Caveats

  • Cystatin C levels can be influenced by factors beyond renal function, including age, male gender, greater body weight, current smoking, and elevated C-reactive protein 5

  • However, these non-renal factors have minimal clinical impact on the interpretation of elevated cystatin C as a marker of reduced kidney function 5

  • In patients with cirrhosis and ascites, cystatin C is particularly useful as serum creatinine often underestimates the degree of renal dysfunction 3

  • The combination of elevated cystatin C with normal creatinine should prompt further evaluation, as significant renal impairment may be present despite reassuring creatinine values 1, 3

When to Refer to Nephrology

  • Referral is not urgently required at this level of kidney function 4

  • Consider nephrology consultation if: GFR continues to decline, albuminuria is present (especially if ≥300 mg/g), difficult-to-control hypertension develops, or unexplained etiology of kidney disease 1

  • Urgent nephrology referral becomes necessary only if GFR falls below 30 mL/min/1.73 m² (Stage G4) or if acute kidney injury develops 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.